Ashish M Kamat

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Venues

Nature medicine

Nature reviews. Urology

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine (2024)
Matthew T Campbell, Amishi Yogesh Shah, Pavlos Msaouel, Nizar M Tannir, Arlene O Siefker-Radtke, Ashish M Kamat, Neema Navai, Colin P N Dinney, Priya Rao, Charles C Guo, Rahul A Sheth, Aradhana M Venkatesan, Rebecca S Slack Tidwell, Shalini Singh Yadav, Aidi Gu, Hong Chen, Marc Macaluso, Fei Duan, Sreyashi Basu, Sonali Jindal, Padmanee Sharma
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle Invasive Bladder Cancer. Cancer research communications (2024)
Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine (2024)
Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine (2024)
Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine (2024)
Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine 30 (8) (2024)
Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine (2024)
Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine (2024)
Antonio Cigliola, Alina Basnet, Joseph M Jacob, Chiara Mercinelli, Valentina Tateo, Damiano Alfio Patanè, Gennady Bratslavsky, Liang Cheng, Petros D Grivas, Ashish M Kamat, Philippe E Spiess, Dean C Pavlick, Douglas I Lin, Jeffery S Ross, Andrea Necchi
Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study. JCO precision oncology 8 (2024)
Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine (2024)
Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine (2024)
Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine (2024)
Roger Li, Paras H Shah, Tyler F Stewart, Jong Kil Nam, Trinity J Bivalacqua, Donald L Lamm, Edward M Uchio, Daniel M Geynisman, Joseph M Jacob, Joshua J Meeks, Rian Dickstein, Shane M Pearce, Seok Ho Kang, Seung Il Jung, Ashish M Kamat, James M Burke, Kirk A Keegan, Gary D Steinberg
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature medicine 30 (8) (2024)
Ashish M Kamat, Andrea B Apolo, Marek Babjuk, Trinity J Bivalacqua, Peter C Black, Roger Buckley, Matthew T Campbell, Eva Compérat, Jason Alexander Efstathiou, Petros D Grivas, Shilpa Gupta, Neil J Kurtz, Donald Lamm, Seth P Lerner, Roger Li, David J McConkey, Joan Palou Redorta, Thomas Powles, Sarah P Psutka, Neal D Shore, Gary D Steinberg, Richard Sylvester, J Alfred Witjes, Matthew D Galsky
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kyle M Rose, Heather L Huelster, Joshua J Meeks, Bishoy M Faltas, Guru P Sonpavde, Seth P Lerner, Jeffrey S Ross, Philippe E Spiess, G Daniel Grass, Rohit K Jain, Ashish M Kamat, Aram Vosoughi, Liang Wang, Xuefeng Wang, Roger Li
Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease. Nature reviews. Urology (2023)
Wei Shen Tan, Emma C Hall, Ashish M Kamat, John D Kelly
Clinical trial design for non-muscle-invasive bladder cancer. Nature reviews. Urology (2023)
Kyle M Rose, Heather L Huelster, Joshua J Meeks, Bishoy M Faltas, Guru P Sonpavde, Seth P Lerner, Jeffrey S Ross, Philippe E Spiess, G Daniel Grass, Rohit K Jain, Ashish M Kamat, Aram Vosoughi, Liang Wang, Xuefeng Wang, Roger Li
Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease. Nature reviews. Urology (2023)
Kyle M Rose, Heather L Huelster, Joshua J Meeks, Bishoy M Faltas, Guru P Sonpavde, Seth P Lerner, Jeffrey S Ross, Philippe E Spiess, G Daniel Grass, Rohit K Jain, Ashish M Kamat, Aram Vosoughi, Liang Wang, Xuefeng Wang, Roger Li
Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease. Nature reviews. Urology (2023)
Jeremy Yuen Chun Teoh, Ashish M Kamat, Peter C Black, Petros Grivas, Shahrokh F Shariat, Marek Babjuk
Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. Nature reviews. Urology 19 (5) (2022)
Niyati Lobo, Nathan A Brooks, Alexandre R Zlotta, Jeffrey D Cirillo, Stephen Boorjian, Peter C Black, Joshua J Meeks, Trinity J Bivalacqua, Paolo Gontero, Gary D Steinberg, David McConkey, Marko Babjuk, J Alfred Witjes, Ashish M Kamat
100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19. Nature reviews. Urology 18 (10) (2021)
Elaine Chang, Andrea B Apolo, Rick Bangs, Stephanie Chisolm, Vinay A Duddalwar, Jason A Efstathiou, Kirsten B Goldberg, Donna E Hansel, Ashish M Kamat, Paul G Kluetz, Seth P Lerner, Elizabeth Plimack, Tatiana Prowell, Harpreet Singh, Daniel Suzman, Evan Y Yu, Hui Zhang, Julia A Beaver, Richard Pazdur, Chana Weinstock, Matthew D Galsky
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop. Nature reviews. Urology (2021)

Ashish M Kamat.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ashish M Kamat